Volume | 247,642 |
|
|||||
News | (2) | ||||||
Day High | 0.7899 | Low High |
|||||
Day Low | 0.74 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.7897 | 0.74 | 0.7899 | 0.7839 | 0.7869 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
712 | 247,642 | $ 0.7652752 | $ 189,514 | - | 0.50 - 5.29 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:58:43 | formt | 316 | $ 0.735 | USD |
Phio Pharmaceuticals Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.91M | 2.44M | - | 0 | -10.83M | -4.43 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Phio Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.7009 | 0.8401 | 0.6512 | 0.762706 | 124,340 | 0.0341 | 4.87% |
1 Month | 0.63 | 1.05 | 0.6101 | 0.8083162 | 528,577 | 0.105 | 16.67% |
3 Months | 0.8525 | 1.15 | 0.604849 | 0.8646279 | 404,581 | -0.1175 | -13.78% |
6 Months | 0.99 | 2.09 | 0.50 | 1.14 | 529,911 | -0.255 | -25.76% |
1 Year | 4.25 | 5.29 | 0.50 | 1.86 | 531,929 | -3.52 | -82.71% |
3 Years | 24.12 | 29.64 | 0.50 | 14.58 | 673,228 | -23.39 | -96.95% |
5 Years | 5.472 | 130.20 | 0.50 | 19.06 | 727,551 | -4.74 | -86.57% |
Phio Pharmaceuticals Description
Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others. |